Analyzing tiny particles in the blood to improve early detection of liver cancer
Covalent Chemistry on Nanosubstrates Enables Molecular Analysis of Purified Extracellular Vesicles in Hepatocellular Carcinoma
This study is looking at tiny particles in the blood that can give us clues about liver cancer, aiming to create better ways to detect and monitor hepatocellular carcinoma, so we can catch it earlier and help patients who might face a recurrence after treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10880272 on NIH RePORTER |
What this research studies
This research focuses on extracellular vesicles (EVs), which are small particles found in the blood that can provide important information about liver cancer. By purifying and analyzing these EVs, the study aims to develop better diagnostic tools for hepatocellular carcinoma (HCC), a common and deadly form of liver cancer. The researchers are using advanced chemical techniques to distinguish between tumor-derived EVs and those from healthy cells, which could lead to earlier detection and better monitoring of the disease. This approach may also help identify patients at risk of cancer recurrence after treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for hepatocellular carcinoma, including those with liver cirrhosis or chronic liver disease.
Not a fit: Patients with liver cancer who are already in advanced stages or those without liver disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate diagnosis of liver cancer, improving treatment outcomes for patients.
How similar studies have performed: Previous research has shown promise in using extracellular vesicles for cancer diagnostics, indicating that this approach could be a significant advancement in the field.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Tseng, Hsian-Rong — University of California Los Angeles
- Study coordinator: Tseng, Hsian-Rong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.